These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31816043)

  • 1. Progressive cardiac arrhythmias and ECG abnormalities in the Huntington's disease BACHD mouse model.
    Zhu Y; Shamblin I; Rodriguez E; Salzer GE; Araysi L; Margolies KA; Halade GV; Litovsky SH; Pogwizd S; Gray M; Huke S
    Hum Mol Genet; 2020 Feb; 29(3):369-381. PubMed ID: 31816043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased oxidative stress and CaMKII activity contribute to electro-mechanical defects in cardiomyocytes from a murine model of Huntington's disease.
    Joviano-Santos JV; Santos-Miranda A; Botelho AFM; de Jesus ICG; Andrade JN; de Oliveira Barreto T; Magalhães-Gomes MPS; Valadão PAC; Cruz JDS; Melo MM; Guatimosim S; Guatimosim C
    FEBS J; 2019 Jan; 286(1):110-123. PubMed ID: 30451379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
    Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
    Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
    Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
    Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's disease.
    Estrada-Sánchez AM; Burroughs CL; Cavaliere S; Barton SJ; Chen S; Yang XW; Rebec GV
    J Neurosci; 2015 Mar; 35(10):4440-51. PubMed ID: 25762686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of defective calcium regulation in cardiorespiratory dysfunction in Huntington's disease.
    Dridi H; Liu X; Yuan Q; Reiken S; Yehia M; Sittenfeld L; Apostolou P; Buron J; Sicard P; Matecki S; Thireau J; Menuet C; Lacampagne A; Marks AR
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32897880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional features of medium spiny neurons in the BACHDΔN17 mouse model of Huntington's Disease.
    Goodliffe J; Rubakovic A; Chang W; Pathak D; Luebke J
    PLoS One; 2020; 15(6):e0234394. PubMed ID: 32574176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.
    Oliveira AO; Osmand A; Outeiro TF; Muchowski PJ; Finkbeiner S
    Hum Mol Genet; 2016 May; 25(9):1677-89. PubMed ID: 26920069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiogram Abnormalities Suggest Aberrant Cardiac Conduction in Huntington's Disease.
    Stephen CD; Hung J; Schifitto G; Hersch SM; Rosas HD
    Mov Disord Clin Pract; 2018; 5(3):306-311. PubMed ID: 30363459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington's disease.
    Soylu-Kucharz R; Baldo B; Petersén Å
    Sci Rep; 2016 Jun; 6():28322. PubMed ID: 27334347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.
    Lu XH; Mattis VB; Wang N; Al-Ramahi I; van den Berg N; Fratantoni SA; Waldvogel H; Greiner E; Osmand A; Elzein K; Xiao J; Dijkstra S; de Pril R; Vinters HV; Faull R; Signer E; Kwak S; Marugan JJ; Botas J; Fischer DF; Svendsen CN; Munoz-Sanjuan I; Yang XW
    Sci Transl Med; 2014 Dec; 6(268):268ra178. PubMed ID: 25540325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease.
    Meunier C; Merienne N; Jollé C; Déglon N; Pellerin L
    Glia; 2016 Nov; 64(11):1841-56. PubMed ID: 27442486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lycium barbarum polysaccharide attenuates the cytotoxicity of mutant huntingtin and increases the activity of AKT.
    Fang F; Peng T; Yang S; Wang W; Zhang Y; Li H
    Int J Dev Neurosci; 2016 Aug; 52():66-74. PubMed ID: 27196502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
    Dufour BD; McBride JL
    Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's disease.
    Shekhar S; Vatsa N; Kumar V; Singh BK; Jamal I; Sharma A; Jana NR
    Hum Mol Genet; 2017 Jan; 26(2):420-429. PubMed ID: 28007908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial physiological properties and interactions with synapses are altered at presymptomatic stages in a mouse model of Huntington's disease pathology.
    Savage JC; St-Pierre MK; Carrier M; El Hajj H; Novak SW; Sanchez MG; Cicchetti F; Tremblay MÈ
    J Neuroinflammation; 2020 Apr; 17(1):98. PubMed ID: 32241286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease.
    Spampanato J; Gu X; Yang XW; Mody I
    Neuroscience; 2008 Dec; 157(3):606-20. PubMed ID: 18854207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.